Get startedLog in
    Picture of Palatin Technologies logo

    PTN — Palatin Technologies News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Palatin Provides Corporate Update And Highlights Strategic Priorities For Calendar Year 2024

    Picture of Palatin Technologies logoPalatin Technologies
    08/01/2024 17:28
    Jan 8 (Reuters) - Palatin Technologies Inc  PTN.A :
    * PALATIN PROVIDES CORPORATE UPDATE AND HIGHLIGHTS STRATEGIC
PRIORITIES FOR CALENDAR YEAR 2024
    * PALATIN TECHNOLOGIES: MELANOCORTIN RECEPTOR 4 (MCR4)
AGONIST +
GLUCAGON LIKE PEPTIDE-1 (GLP-1) PHASE 2 CLINICAL STUDY TARGETED
TO START 1Q CY 2024
    * PALATIN TECHNOLOGIES: MELANOCORTIN RECEPTOR 4 (MCR4)
AGONIST +
GLUCAGON LIKE PEPTIDE-1 (GLP-1) PHASE 2 TOPLINE RESULTS EXPECTED
IN 2H CY 2024

Source text for Eikon:  ID:nPn1cp6TCa 
Further company coverage:  PTN.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Palatin Technologies

    See all news